--- title: "12 Health Care Stocks Moving In Tuesday's Pre-Market Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/278555488.md" description: "In Tuesday's pre-market session, Catheter Precision (VTAK) shares surged 69.3% to $2.32, while MiNK Therapeutics (INKT) rose 54.44% to $16.14. Other gainers included BioRestorative Therapies (BRTX) up 36.55% to $0.32 and Zevra Therapeutics (ZVRA) up 16.55% to $10.63. Conversely, Pomdoctor (POM) shares fell 20.2% to $0.35, and BioNTech (BNTX) decreased 16.27% to $85.54. AquaBounty Techs (AQB) and Evotec (EVO) also saw declines of 13.96% and 13.87%, respectively." datetime: "2026-03-10T12:06:01.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/278555488.md) - [en](https://longbridge.com/en/news/278555488.md) - [zh-HK](https://longbridge.com/zh-HK/news/278555488.md) --- # 12 Health Care Stocks Moving In Tuesday's Pre-Market Session ### Gainers - **Catheter Precision** (AMEX:VTAK) shares moved upwards by 69.3% to $2.32 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.3 million. - **MiNK Therapeutics** (NASDAQ:INKT) stock rose 54.44% to $16.14. The company's market cap stands at $49.0 million. - **BioRestorative Therapies** (NASDAQ:BRTX) shares rose 36.55% to $0.32. The market value of their outstanding shares is at $5.0 million. - **Zevra Therapeutics** (NASDAQ:ZVRA) stock moved upwards by 16.55% to $10.63. The company's market cap stands at $513.4 million. As per the news, the Q4 earnings report came out yesterday. - **HeartBeam** (NASDAQ:BEAT) stock moved upwards by 16.21% to $1.72. The company's market cap stands at $50.9 million. - **ENDRA Life Sciences** (NASDAQ:NDRA) stock moved upwards by 15.86% to $3.96. The market value of their outstanding shares is at $3.9 million. ### Losers - **Pomdoctor** (NASDAQ:POM) shares declined by 20.2% to $0.35 during Tuesday's pre-market session. The company's market cap stands at $52.0 million. - **BioNTech** (NASDAQ:BNTX) stock decreased by 16.27% to $85.54. The company's market cap stands at $24.5 billion. As per the news, the Q4 earnings report came out today. - **AquaBounty Techs** (NASDAQ:AQB) stock decreased by 13.96% to $0.77. The market value of their outstanding shares is at $3.4 million. - **Evotec** (NASDAQ:EVO) shares fell 13.87% to $2.61. The market value of their outstanding shares is at $1.0 billion. - **BioAtla** (NASDAQ:BCAB) stock decreased by 9.84% to $0.17. The company's market cap stands at $14.0 million. - **Spectral AI** (NASDAQ:MDAI) stock fell 7.81% to $1.3. The market value of their outstanding shares is at $43.2 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [XHE.US](https://longbridge.com/en/quote/XHE.US.md) - [ZVRA.US](https://longbridge.com/en/quote/ZVRA.US.md) - [IHI.US](https://longbridge.com/en/quote/IHI.US.md) - [VTAK.US](https://longbridge.com/en/quote/VTAK.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [IHE.US](https://longbridge.com/en/quote/IHE.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [VHT.US](https://longbridge.com/en/quote/VHT.US.md) - [BRTX.US](https://longbridge.com/en/quote/BRTX.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [INKT.US](https://longbridge.com/en/quote/INKT.US.md) - [POM.US](https://longbridge.com/en/quote/POM.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md) - [XLV.US](https://longbridge.com/en/quote/XLV.US.md) - [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [BNTX.US](https://longbridge.com/en/quote/BNTX.US.md) ## Related News & Research - [Duality Biotherapeutics Exercises U.S. Cost and Profit-Sharing Option for BioNTech ADC](https://longbridge.com/en/news/286169551.md) - [Roth MKM Sticks to Their Buy Rating for Capricor Therapeutics (CAPR)](https://longbridge.com/en/news/286497683.md) - [POMDOCTOR LIMITED Announces Fiscal Year 2025 Financial Results | POM Stock News](https://longbridge.com/en/news/286463818.md) - [Resona Asset Management Co. Ltd. Cuts Position in Danaher Corporation $DHR](https://longbridge.com/en/news/286897088.md) - [Analyst Reaffirms Buy on PAVmed, Citing Oncology Platform Momentum and Partnerships; Price Target Maintained at $16](https://longbridge.com/en/news/286945953.md)